Study of Tryptophan Metabolites in Bladder Cancer and Other Malignancies
Author Information
Author(s): A. S. Khalafallah, M. A. M. Abul-Fadl
Primary Institution: Cairo University
Hypothesis
The study investigates the role of tryptophan metabolites in the development of bladder cancer and other malignancies in Egypt.
Conclusion
The study found significant differences in the urinary excretion of tryptophan metabolites between patients with bladder cancer and other malignancies.
Supporting Evidence
- The study showed that bladder cancer patients had significantly higher levels of certain tryptophan metabolites compared to normal subjects.
- After tryptophan loading, the excretion of 3-hydroxyanthranilic acid increased significantly in bladder cancer patients.
- Normal subjects showed a different pattern of metabolite excretion compared to those with malignancies.
Takeaway
Doctors looked at how certain substances from tryptophan in urine can help understand bladder cancer and other cancers in Egypt.
Methodology
The study involved colorimetric, fluorimetric, and chromatographic analysis of urine samples collected before and after administering a tryptophan loading dose.
Limitations
The study may not account for all variables affecting metabolite excretion, such as dietary differences.
Participant Demographics
Participants included 100 normal subjects aged 18-55, 100 with simple bilharziasis, 100 with complicated bilharziasis, and 100 with bladder cancer.
Want to read the original?
Access the complete publication on the publisher's website